Page last updated: 2024-12-07

1,5-diazabicyclo(4.3.0)non-5-ene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,5-diazabicyclo(4.3.0)non-5-ene: inhibitor of indolamine-N-methyltransferase; RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID76349
CHEMBL ID3303308
CHEBI ID183972
SCHEMBL ID2927
MeSH IDM0061395

Synonyms (56)

Synonym
1,5-diazabicyclo-[4.3.0]non-5-ene
unii-978m4ol12q
einecs 221-087-3
978m4ol12q ,
nsc 118106
pyrrolo[1,2-a]pyrimidine, 2,3,4,6,7,8-hexahydro-
1,5-diazabicyclo[4.3.0]non-5-ene
3001-72-7
nsc118106
nsc-118106
nbu ,
inchi=1/c7h12n2/c1-3-7-8-4-2-6-9(7)5-1/h1-6h
1,5-diazabicyclo[4.3.0]non-5-ene, 98%
1,5-diazabicyclo(4.3.0)non-5-ene
1,5-diazabicyclo[4.3.0]-5-nonene
D1313
1,5-diazabicyclo[4.3.0]-non-5-ene
2,3,4,6,7,8-hexahydropyrrolo[1,2-a]pyrimidine
CHEBI:183972
2h,3h,4h,6h,7h,8h-pyrrolo[1,2-a]pyrimidine
1,5-diazabicyclo[4,3,0]non-5-ene
A820145
AKOS005206778
FT-0606950
CHEMBL3303308
SCHEMBL2927
1,5-diazabicyclo(4.3.0)non-5-ene [mi]
2,3,4,6,7,8-hexahydropyrrolo(1,2-a)pyrimidine
AKOS025243303
1,5-diazabicyclo-[4,3,0]-non-5-ene
1,5-diaza-bicyclo[4.3.0] non-5-ene
1,5-diazabicyclo[4.3.0] -5-nonene
1,5-diazabicyclo-[4.3.0] non-5-ene
2,3,4,6,7,8-hexahydro-pyrrolo[1,2-a]pyrimidine
1,5-diazabicyclo [4.3.0]-5-nonene
1,5-diazabicyclo -[4.3.0]non-5-ene
1,5-diaza- bicylo-[4,3,0]-non-5-ene
1,5-diazabicyclo[4,3,0]-5-nonene
1,5-diazabicyclo [4.3.0]non-5-ene
1,5-diazabicyclo(4,3,0)non-5-ene
1,5-diaza-bicyclo[4.3.0]non-5-ene
Q-101285
2,3,4,6,7,8-hexahydropyrrolo[1,2-a]pyrimidine #
mfcd00005554
F8889-2155
DTXSID10184087
1,5-diazabicyclo[4.3.0]non-5-ene, purum, >=98.0% (gc)
Q307070
2,3,4,6,7,8-hexahydropyrrolo[1,2-a]pyrimidine pyrrolo[1,2-a]pyrimidine, 2,3,4,6,7,8-hexahydro- pyrrolidino[1,2:a]1,4,5,6-tetrahydro-pyrimidine
BCP30896
STL185618
C93461
2,3,4,6,7,8-hexahydropyrrolo[1,2-a]pyrimidine pound dbn pound(c)
CS-W016569
EN300-39944
Z406355328
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
pyrrolopyrimidine
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (11.11)18.7374
1990's0 (0.00)18.2507
2000's3 (33.33)29.6817
2010's4 (44.44)24.3611
2020's1 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.87

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.87 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.38 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.87)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]